Showing results (11-20 of 2,336) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|July 7, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, et al.Clinical Lung Cancer|November 28, 2022
Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cmJessica H Tran, Grace Mhango, Henry S Park, et al.Clinical Lung Cancer|November 29, 2022
The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based AnalysisBohao Liu, Zhiyu Wang, Heng Zhao, et al.Clinical Lung Cancer|June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based RegimensSarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.Clinical Lung Cancer|April 11, 2022
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to ErlotinibD Ross Camidge, Teresa Moran, Ingel Demedts, et al.Clinical Lung Cancer|July 16, 2010
Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic realityRonan J Kelly, James L Gulley, Giuseppe GiacconeClinical Lung Cancer|July 16, 2010
Src inhibitors in lung cancer: current status and future directionsSacha I Rothschild, Oliver Gautschi, Eric B Haura, et al.Clinical Lung Cancer|July 16, 2010
Phase I and pharmacologic study of weekly bolus topotecan for advanced non-small-cell lung cancerNoriyuki Masuda, Kaoru Matsui, Shunichi Negoro, et al.Clinical Lung Cancer|November 11, 2010
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicitySameer Mahesh, Ashish Saxena, Xuan Qiu, et al.Clinical Lung Cancer|January 29, 2011
The potential application of zoledronic acid as anticancer therapy in patients with non-small-cell lung cancerReshma Mahtani, Raza Khan, Mohammad JahanzebPageof 234